Skip to main content
Premium Trial:

Request an Annual Quote

Lion, ACE Enter Into Proteomics Collaboration

NEW YORK, Nov. 6 – Lion Bioscience and ACE BioSciences have entered into a proteomics-based collaboration, the companies said on Tuesday. 

Under the terms of the deal, Lion, based in Heidelberg, Germany, has licensed its SRS platform as well as its piSCOUT, bioSCOUT, and genomeSCOUT software to ACE. 

In exchange, ACE, of Odense, Denmark, intends to generate protein-protein interaction data that will be put into a library to be connected to SCOUT and made available exclusively to the companies’ customers. 

“Our main focus isn’t to generate data and we don’t want to compete with Incyte to set up databases, so this is the most efficient way for us to [expand] our products,“ said Lion spokeswoman Andrea Kreisselmeier. 

Ace said that by using Lion’s software it would be able to link genomics data with proteomics data.  

“With the integrated software solutions of Lion we can most efficiently link theoretical information from comparative genomics with the scientific data of the ‘real world’ experimental or functional proteomics results,” Angus King, chief scientific officer at ACE BioSciences, said in a statement. 

The companies did not disclose the financial terms of the deal. 

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.